This announcement is a separate document:
荃信生物-B：(1) 與中美華東就QX005N的開發及潛在商業化合作有關的持續關連交易 (2) 建議委任董事及非職工代表監事及(3) 臨時股東大會通告
QYUNS-B: (1) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE DEVELOPMENT AND POTENTIALCOMMERCIALIZATION PARTNERSHIP OF QX005N WITH ZHONGMEI HUADONG (2) PROPOSED APPOINTMENT OF DIRECTORS AND NON-EMPLOYEE REPRESENTATIVE SUPERVISORS AND (3) NOTICE OF EGM
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.